Introduction. Matrix metalloproteinase enzymes (MMPs) play important role in inflammation, malignant cell proliferation, invasion and angiogenesis by mediating extracellular matrix degradation. Doxycycline, a synthetic tetracycline, behaves as a MMP inhibitor at a subantimicrobial dose and inhibits tumor cell proliferation, invasion and angiogenesis. The aberrant activity of nuclear factor kappa B (NF-kB) causes activation of MMPs and thereby proliferation and invasion of cancer cells. The aim of this study was to investigate the effects of doxycycline on the expression of MMPs in lipopolysaccharide (LPS)-induced PC3 human prostate cancer cells and the possible role of NF-kB signaling. Material and methods. PC3 cells were incubated with LPS (0.5 µg/mL) for 24 h in the presence or absence of doxycycline (5 µg/mL). The effects of LPS and doxycycline on the expressions of MMP-2, MMP-8, MMP-9, MMP-10, NF-kB/p65, IkB-a, p-IkB-a, IKK-b were examined by Western blotting and immunohistochemistry in PC3 cells. Furthermore, relative proteinase activities of MMP-2 and MMP-9 were determined by gelatin zymography. Results. LPS increased expression and activity of MMP-9 and expression of MMP-8, MMP-10, NF-kB/p65, p-IkB-a, IKK-b and doxycycline down-regulated its effects with the exception of MMP-10 expression. The expression of MMP-2 and IkB-a was affected by neither LPS nor doxycycline. Conclusions. Our findings indicate that doxycycline inhibits the expression of various MMPs and NF-kB signaling may play a role in the regulation of MMPs expression in LPS-induced PC3 human prostate cancer cells.
Introduction
Prostate cancer is the third cause of cancer-associated death in men after lung cancer in developed countries [1] [2] [3] . Although early detection of prostate cancer is crucial, several biomarkers for early screening are still controversial [4, 5] . Over 70% of the patients are cured after various primary treatment options such as surgery, radiotherapy and androgen-deprivation therapy [2, 6] . However, recurrence which occurs in 34% of the patients within 5 years and in 46% of the patients after 10 years limits management of the disease and prevents better cancer control and lower morbidity [2, 6] . Therefore, understanding the underlying mechanism of the disease may be critical in the development of novel approaches for appropriate diagnosis and treatment.
Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases which degrade extracellular matrix (ECM) components and play an essential role in the processes of cancerogenesis including tumor growth, angiogenesis, invasion and me- www.fhc.viamedica.pl tastasis [7, 8] . MMPs were divided into subgroups of collagenases (MMPs-1, -8, -13), gelatinases (MMPs-2, -9), stromelysins (MMPs-3, -10, -11), membrane-type MMPs (MMPs-14 to -17), and other MMPs (e.g., MMP-12) [9] . Activity of MMPs is tightly regulated by endogenous tissue inhibitors of MMPs (TIMPs) [9] . In numerous clinical and experimental studies related to various types of cancers, overexpression of MMPs, in particular MMP-2 and MMP-9 (gelatinases) and low levels of TIMPs were reported [7, 10, 11] . Accordingly, targeting MMPs may be an efficient therapeutic strategy to control tumorigenesis, invasion and metastasis [12] .
Tetracyclines at the subantimicrobial dose inhibit MMPs by the mechanism independent from their antimicrobial activity [13] . They inhibit MMPs via chelating the catalytic Zn +2 ion in the active site of MMP molecule [14] .
Tetracyclines have high affinity to bone tissue which serves as a drug reservoir. They also inhibit metastasis of cancer cells to the bone and protect connective tissue from excessive breakdown mediated by MMPs [2, 15, 16] . Doxycycline at subantimicrobial dose is the unique MMP inhibitor which was approved by Food and Drug Administration for the treatment of periodontal diseases [17, 18] . However, molecular mechanisms responsible for the inhibitory effect of doxycycline on MMPs have yet not been fully understood.
Nuclear Factor Kappa B (NF-kB) belongs to a family of transcription factors which provide a pivotal link between inflammation and cancer [19, 20] . NF-kB activity is regulated by two main pathways which are known as the classical (canonical) pathway and the alternative one. The classical pathway plays a crucial role in the control of inflammation. In this pathway, Rel A (p65)-p50 dimer which consists of two members of NF--kB family exists in an inactive form bound to inhibitory IkB-a (inhibitor of kappa B-a) molecule. Phosphorylation of the IKK (IkB kinase) complex that consists of IKKa, IKKb, and IKKg, leads to the phosphorylation of inhibitory IkB-a molecule and to the release of Rel A (p65)-p50 from Rel A (p65)-p50-IkB-a complex. Then, IkB-a is marked for degradation by the proteasome pathway and Rel A (p65)-p50 translocates to cell nucleus. In nucleus, Rel A (p65)-p50 binds to the promoter region of target genes and induces expression of NF-kB-related genes. For the termination of NF-kB signaling, cytoplasmic synthesis of new IkB-a is necessary. The new IkB-a enters the nucleus and binds to the Rel A (p65)-p50. This causes the dissociation of Rel A (p65)-p50-IkB-a complex from DNA and its re-exportation to the cytoplasm [21] [22] [23] .
Increased activation of NF-kB signaling through proinflammatory stimuli in tumor microenvironment has been demonstrated to stimulate proliferation, migration and metastasis of cancer cells and inhibit apoptosis in many human malignancies including prostate cancer [20, 23, 24] . More importantly, in breast cancer patients NF-kB activation promoted up-regulation of MMP-9 which was closely associated with shorter lifespan [25] . All of the studies related to the NF-kB-dependent-MMP regulation in prostate cancer focused on the regulation of gelatinases (MMP-2 and -9) [23, 26] . However, the role of NF-kB activation in the gene regulation of MMPs from the subgroups of collagenases and stromelysins in prostate cancer has not been studied yet. Additionally, the modulating effects of lipopolysaccharide (LPS) which is an inflammatory stimulus on NF-kB translocation and regulation of MMPs in prostate cancer remains to be investigated.
On the other hand, various anticancer agents were reported to inhibit NF-kB signaling-mediated MMP up-regulation in prostate cancer [27, 28] . Similarly, doxycycline was shown to suppress NF-kB signaling in LPS-treated microglial cells [29] . However, the effects of doxycycline on NF-kB signaling and regulation of MMP expression in prostate cancer have yet not been examined.
Hence, in the current study, we investigated the effects of doxycycline at subantimicrobial dose on the regulation of the expression of MMPs from diverse subgroups including gelatinases, collagenases and stromelysins, and a possible contribution of NF-kB signaling to this expression in LPS-induced PC3 human prostate cancer cells. Induction and treatment of the cells. Cells were seeded into 12-well plates. When they became confluent, they were induced with 0.5 µg/mL LPS [30, 31] in the presence or absence of 5 µg/mL doxycycline [32] for 24 h. The optimal concentration of LPS and doxycycline were determined in consideration of our preliminary studies (data not shown). Uninduced and untreated cells were maintained as control cells for the same period of time. In all experiments doxycycline and LPS were added into the culture media at the same time. Cells were collected and stored at -80°C for further investigations.
Material and methods

Reagents
Cell lysis and protein extraction. Cells were resuspended in 250 µL of lysis buffer (20 mM HEPES pH = 7.4, 0.1% Triton X-100, 0.2 mM EDTA, 300 mM NaCl) then collected from culture plates and transferred to Eppendorf tubes. The tubes were incubated on ice and centrifuged at 13,000 rpm for 30 min and then supernatants were collected. Protein concentration in lysates was measured fluorometrically by using Quant-IT protein assay kit (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's protocol.
Western blotting. Under standard conditions, 25 µg of protein from each cell extract was loaded to 10% SDS-PAGE gels and separated by BioRad vertical electrophoresis system (Mini-PROTEAN Tetra Cell, BioRad Cat No:165-8001, Hempstead, UK). Then, the gels were transferred to PVDF membrane (Amersham, Buckinghamshire, UK) by semi-dry transfer blotter (VWR, V20-SDB, Tingalpa, Australia). PVDF membranes were blocked with blocking solution (PBS-T, Phosphate-Buffered Saline solution containing 5% dry milk and 0.1% Tween 20) for 1 hour. Incubations with primary and secondary antibody were carried out using PBS-T containing 5% dry milk at 4 o C overnight and immunoblotted with primary antibodies. Primary antibodies used were rabbit antibodies specific for MMP-9, MMP-10, MMP-8, NF-kB/p65, IkB-a, phosphorylated IkB-a (p-IkB-a), IKK-b, b-actin and mouse antibody specific for MMP-2. Membranes were developed using horseradish peroxidase-coupled secondary antibody and Western blotting (WB) luminol reagent (ImmunoCruz). Western blots were photographed by Fusion FX7 (Vilbert Lourmat, Collégien, France) and optical densities of blotting images were quantified by ImageJ software (ImageJ 1.46r, National Institutes of Health, Bethesda, MD, USA) and were normalized with b-actin.
Gelatin zymography. Equal protein concentration (25 µg) of each zymography sample was loaded into 10% polyacrylamide gels containing 2 mg/mL gelatin and were subjected to SDS-polyacrylamide gel electrophoresis. Then, SDS was removed from the gels and gels were incubated at 37 o C for 48 h in incubation buffer (50 mM Tris-HCl, pH 8.0, 50 mM NaCl, 10 mM Ca 2 Cl, and 0.05% Triton X-100). After the incubation period, gels were stained in 0.2% Coomassie Brilliant Blue. Images of the gels were photographed by using Fusion FX7. Gelatinase activity was detected as clear bands on dark backgrounds. Densitometric analysis of the bands was performed using ImageJ software.
Immunohistochemistry. Cell medium and cell suspension were added on to coverslips placed in six well plates. The cells were kept in a humidified atmosphere containing 5% CO 2 at 37°C for 24 h to allow cells to adhere to coverslips. Then, the adhered cells were incubated with LPS and/or doxycycline for the next 24 h in a humidified atmosphere containing 5% CO 2 at 37°C. Some of the coverslips were kept as control cells incubated without LPS and doxycycline. After treatment period, cell media were removed and cells were fixed in 96% ethanol for 15 min. Then, ethanol was removed, cells on the cover slips were rehydrated through alcohol series and then washed with distilled water. Following these steps, the cells were treated with a solution of 0.125% trypsin (diluted with Digest All 2A; 00-3008, Zymed, San Francisco, CA, USA) for 5 min at 37°C. Then cells were incubated in a solution of 3% H 2 O 2 for 5 min and with normal serum blocking solution. Coverslips were first incubated in a humidified chamber for 18 h at 4°C with primary antibodies against MMP-8, MMP-9, NF-kB/p65, IKK-b, p-IkB-a and thereafter with biotinylated IgG, and then with streptavidin conjugated to horseradish peroxidase according to kit instructions (85-9043, Invitrogen). Finally, coverslips were stained with DAB (diaminobenzidine, 1718096, Roche, Mannheim, Germany) and counter-stained with Mayer's hematoxylin. After that, images of cells were captured by using a BX-51 light microscope (Olympus, Tokyo, Japan) equipped with a high-resolution video camera (Olympus DP-71). The intensity of immunopositivity for each protein was evaluated using immunoscoring scale by two histologists, who were blinded to the treatment of the samples. The immunoscoring was performed semi-quantitatively, by considering the degree of positive cytoplasmic staining of cells and by scoring according to the following scale: negative (0), weak (1), moderate (2) and strong (3) immunoreactivity. A mean score was calculated for each sample. Then, mean scores were used to categorize immunopositivity as weak (< 1.5) or strong (> 1.5). www.fhc.viamedica.pl gelatin zymography were carried out using paired Student's t-test. Chi-square test was performed to evaluate the statistical difference of immunostaining between the groups. P ≤ 0.05 was considered statistically significant.
Results
Effects of LPS and doxycycline on the expression and activities of gelatinases
We examined the effects of concomitant LPS (0.5 µg/mL) and doxycycline (5 µg/mL) treatment for 24 h on gelatinases (MMP-2 and MMP-9) by gelatin zymography and WB analysis in PC3 cells. In zymogram, we determined barely visible bands of lysis representing pro MMP-9 and pro MMP-2 at molecular positions of 97 kDa and 72 kDa, respectively, and the active MMP-2 at molecular position of 68 kDa (Figure 1) . Bands of lysis of both pro MMP-9 and pro MMP-2 as well as active MMP-2 were too faint for efficient quantitation in PC3 cells.
Gelatin zymography analysis demonstrated that incubation with LPS for 24 h significantly increased active MMP-9 level in LPS-induced PC3 cells (Figure 1 ). Doxycycline treatment for 24 h significantly inhibited this effect (Figure 1 ). However, doxycycline treatment for the same period had no effect on PC3 cells that were not incubated with LPS ( Figure 1) .
The expression of MMP-9 was also studied by WB analysis. Consonantly with our zymography findings, the WB results showed that MMP-9 expression was significantly up-regulated in LPS-induced cells compared to non-induced control cells (Figure 2) . However, doxycycline treatment significantly inhibited MMP-9 expression in LPS-induced cells (Figure 2 ). In parallel with the data from gelatin zymography analysis, WB results also demonstrated that MMP-2 expression was not affected by either induction with LPS or doxycycline treatment in PC3 cells (Figure 2 ).
Immunohistochemical analysis of MMP-9 expression in PC3 cells
To confirm the effects of induction with LPS and doxycycline treatment on MMP-9 expression, we evaluated the intensity of positive staining of MMP-9 by conducting immunohistochemical (IHC) staining and immunoscoring.
The data showed that LPS caused a significant increase in the intensity rate of positive immunostaining of cells with an anti-MMP-9 antibody, but doxycycline significantly decreased immunopositivity of MMP-9 in LPS-induced PC3 cells (Table 1, Figure 3 ). Doxycycline did not affect MMP-9 expression in control, LPS-uninduced PC3 cells (Table 1, Figure 3 ). These results indicate that doxycycline inhibits LPS-induced expression and activity of MMP-9 (gelatinase-2) in PC3 prostate cancer cells.
Effects of LPS and doxycycline on the expression of MMP-8 and MMP-10
WB findings evidenced that LPS stimulated MMP-8 expression but doxycycline treatment for 24 h significantly down-regulated MMP-8 expression in LPS-induced PC3 cells. Doxycycline treatment for 24 h did not change MMP-8 expression level in uninduced PC3 cells (Figure 2) . WB showed that LPS significantly up-regulated MMP-10 expression, while doxycycline treatment did not change MMP-10 expression level in LPS-induced PC3 cells (Figure 2 ).
In addition, we assessed MMP-8 expression by performing IHC staining and immunoscoring Figure 3 ). However, intensity of MMP-8 immunostaining significantly declined with doxycycline treatment for 24 h in LPS-induced PC3 cells (Table 1, Figure 3 ).
Effects of LPS and doxycycline on IKK/IkB/NF-kB axis
In order to determine the effects of LPS and doxycycline on NF-kB signaling pathway proteins, we examined the expressions of NF-kB/p65, IKK-b, IkB-a and p-IkB-a in the presence or absence of LPS and/or doxycycline by performing WB analysis and IHC staining. level, this effect was not statistically significant in LPS-induced PC3 cells (Figure 4) . WB analyses showed that IkB-a expression was not affected by either induction with LPS or doxycycline treatment in PC3 cells (Figure 4) . WB analyses also showed that p-IkB-a expression was significantly up-regulated by LPS; however, doxycycline inhibited the p-IkB-a up-regulation (Figure 4) .
To corroborate the data from WB experiments, we assessed the immunopositive staining scores for NF-kB/p65, IKK-b and p-IkB-a. We observed that immunopositive staining scores of NF-kB/p65, IKK-b and p-IkB-a were significantly higher in LPS-induced cells than the scores in uninduced control cells (Table 1, Figure 3) .
We also observed more intense immunostaining for NF-kB/p65 in the nuclei of LPS-induced cells, which is the landmark of increased nuclear translocation of NF-kB (Figure 3) . IHC analyses also revealed that doxycycline treatment significantly decreased immunopositive staining and immunopositive scores for NF-kB/p65, IKK-b and p-IkB-a in LPS-induced PC3 Figure 3 ). We also observed apparently impaired staining in cell nucleus where NF-kB/p65 is translocated in LPS-induced doxycycline-treated cells compared with LPS-induced control cells (Figure 3 ).
Discussion
In this study, we investigated the effects of doxycycline at subantimicrobial dose on the regulation of MMPs from diverse subgroups and the contribution of NF-kB signaling as a possible underlying mechanism in LPS-induced PC3 human prostate cancer bone metastasis cells. In this context, we evaluated the expression and activity of proteinases representing different subgroups of MMPs: MMP-2/-9 (gelatinases), expression of MMP-8 (collagenases) and MMP-10 (stromelysins) in the presence or absence of doxycycline in LPS-induced or uninduced PC3 cells. We also have examined in these cells the expression levels of the members of the classical NF-kB activation pathway including NF-kB/p65, activator kinase IKK-b, which has a pivotal role in NF-kB activation, and inhibitor IkB-a.
We found that the expression of NF-kB/p65, IKK-b and p-IkB-a was significantly up-regulated in parallel with the increased expression of MMP-9, -8 and -10 in LPS-induced PC3 cells. These results for the first time indicate that LPS-induced up-regulation of MMP-8, -9 and -10 from different subgroups of MMPs may be at least partly mediated by the activation of NF-kB signaling in PC3 human prostate cancer cells.
Consistent with our evidence, a recent study reported that LPS-induced TLR4 activation leads to NF-kB activation and up-regulation of MMP-2 and -9 in colorectal cancer cells [33] . Similarly, it was previously found that metadherin, a newly identified oncogene inhibits LPS-induced NF-kB activation and downstream MMP-9 regulation in the migration and invasion of breast cancer cells [34] . In line with these reports, UDN glycoprotein isolated from Ulmus davidiana Nakai was demonstrated in LPS-induced colon cancer epithelial cell line HCT-116, to block activities of NF-kB and activator protein-1 (AP-1) and had inhibitory effect on MMP-9 activation [35] . Moreover, it was reported that LPS stimulated NF-kB activation and promoted the invasiveness of pancreatic cancer cells by increasing MMP-9 mRNA expression [36] . Interestingly, in all these studies, MMP-9 was implicated in LPS-induced NF-kB activation-mediated downstream MMP gene regulation in diverse cancer cell types. However, the effect of LPS on NF-kB activation and related MMP regulation in prostate cancer have not been elucidated yet. In this respect, our novel findings show that LPS, a well-known TLR4 ligand, may affect NF-kB signaling and downstream MMP gene regulation in PC3 prostate cancer cells.
In a limited number of studies, the role of MMP-8 and -10 were examined in prostate cancer cell proliferation, migration and invasion [37, 38] . Nevertheless, previous studies have not addressed the relationship between NF-kB signaling and downstream gene regulation of MMP-8 and-10 in prostate cancer. For the first time, our study suggests that LPS-induced NF-kB activation may contribute to the regulation of different classes of MMPs in PC3 prostate cancer cells.
Our study is the first to indicate inhibitory effect of doxycycline on the expression of MMPs in LPS-induced PC3 human prostate cancer cells. Recent studies also showed that doxycycline inhibited activity of gelatinases and diminished tumor growth, invasion and metastasis in osteosarcoma, and lung, ovarian, cervical and oral cancer cell lines [39] [40] [41] [42] . Similarly, zoledronate, which is nitrogen-containing bisphosphonate, exerts antitumoral effects by suppressing MMP expression and/or activity in various cancers [43, 44] . Recently, we have also reported that zoledronate downregulated MMP-2 and -9 expression and activities in PC3 prostate cancer cells [45] . Although LPS caused the up-regulation of MMP-10 expression, doxycycline had no effect on MMP-10 expression in PC3 cells. In this respect, further studies may help to clarify the basis for the lack of inhibitory effect of doxycycline on MMP-10 expression in PC3 cells.
To enlighten the molecular mechanisms responsible for the inhibitory effect of doxycycline on MMPs in LPS-induced PC3 human prostate cancer cells, we also assessed the contribution of NF-kB signaling to this effect. Interestingly, there are only a few studies regarding the effects of doxycycline on NF-kB-dependent MMP gene regulation. In one of the previous studies doxycycline was shown to inhibit phosphorylation and nuclear translocation of the NF-kB-p65 and NF-kB-induced MMP-9 expression in lung cancer cell migration and invasion [41] . In another study in human dermal fibroblasts doxycycline inhibited TNF-a--induced NF-kB-mediated MMP-2 expression but not MMP-9 expression [46] . Consistently with the results of these studies, we observed that inhibition of MMP-9 and -8 expression by doxycycline was associated with the down-regulation in the expression of NF-kB/p65, IKK-b and the reduction in the phosphorylation of IkB-a in PC3 prostate cancer cells. The inhibitory effect of doxycycline on IKK-b expression was also supported by our IHC findings. Thus, the present study provides original evidence that down-regulation of MMPs, in particular MMP-9 and -8, caused by doxycycline may be associated with the inhibition of NF-kB signaling pathway in LPS-induced PC3 cells. 
